Cargando…
Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents
Prostate Cancer (PCa) is the most frequently diagnosed cancer in men in their late '50s. PCa growth is mainly due to the activation of the androgen receptor by androgens. The treatment for PCa may involve surgery, hormonal therapy, and oral chemotherapeutic drugs. A structural based molecular d...
Autores principales: | Arjun, H. A., Elancheran, Ramakrishnan, Manikandan, N., Lakshmithendral, K., Ramanathan, Muthiah, Bhattacharjee, Atanu, Lokanath, N. K., Kabilan, Senthamaraikannan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636335/ https://www.ncbi.nlm.nih.gov/pubmed/31355179 http://dx.doi.org/10.3389/fchem.2019.00474 |
Ejemplares similares
Ejemplares similares
-
Corrigendum: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents
por: Arjun, H. A., et al.
Publicado: (2019) -
Crystal structure, DFT and Hirshfeld surface analysis of (E)-N′-[(1-chloro-3,4-dihydronaphthalen-2-yl)methylidene]benzohydrazide monohydrate
por: Arjun, H. A., et al.
Publicado: (2020) -
Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents
Publicado: (2023) -
Retraction: Corrigendum: Design, synthesis, and biological evaluation of (E)-N'-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents
Publicado: (2023) -
1-Chloro-4-(3,4-dichlorophenyl)-3,4-dihydronaphthalene-2-carbaldehyde
por: Devarajegowda, H. C., et al.
Publicado: (2011)